Mark A. Winters

siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters

Zhuang Liu, Mark A. Winters, Mark Holodniy et al. · Angewandte Chemie International Edition · 2007 · 665 citations

Pharmacy, Immunology, Pharmaceutics +17

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

John D. Baxter, Douglas L. Mayers, Deborah Wentworth et al. · AIDS · 2000 · 502 citations

Pharmacy, Pharmacotherapy, Molecular Virology +16

Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART)

Clive M. Gray, Jody Lawrence, Jonathan Schapiro et al. · The Journal of Immunology · 1999 · 268 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Christopher Koh, Laëtitia Canini, Harel Dahari et al. · The Lancet Infectious Diseases · 2015 · 263 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr et al. · Nature Medicine · 2009 · 263 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13